Jones Lang LaSalle (NYSE: JLL) director sells 2,500 pre-planned shares

Rhea-AI Filing Summary

Jones Lang LaSalle Inc. director Deborah H. McAneny reported an open-market sale of 2,500 shares of common stock at $300.50 per share. After this transaction, she directly holds 14,985 shares. The sale was executed under a pre-arranged Rule 10b5-1(c) trading plan adopted on December 9, 2025, indicating the trades were scheduled in advance rather than timed discretionarily.

Insider Trade Summary 10b5-1

Net Seller: 2,500 shares ($751,250)

Net Sell 1 txn

Insider MCANENY DEBORAH H

Role Director

Sold 2,500 shs ($751K)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,500	$300.50	$751K

Holdings After Transaction: Common Stock — 14,985 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCANENY DEBORAH H

(Last) (First) (Middle)

200 E. RANDOLPH DRIVE

(Street)

CHICAGO IL 60601

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
JONES LANG LASALLE INC [ JLL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/10/2026		S(1)		2,500	D	$300.5	14,985	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares sold pursuant to a Rule 10b5-1(c) plan that was adopted by the Reporting Person on December 9, 2025.

	/s/ Alan K. Tse as attorney-in-fact for Deborah H. McAneny	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did JLL director Deborah McAneny report?

Deborah H. McAneny reported an open-market sale of 2,500 shares of Jones Lang LaSalle common stock at $300.50 per share. This Form 4 filing details a routine director transaction rather than a change in company operations or strategy.

How many JLL shares does Deborah McAneny hold after the reported sale?

Following the sale, Deborah H. McAneny directly holds 14,985 shares of Jones Lang LaSalle common stock. This post-transaction balance is disclosed in the Form 4 and shows she retains a meaningful equity stake after the reported open-market sale.

At what price were the JLL shares sold in this Form 4 filing?

The reported transaction shows 2,500 Jones Lang LaSalle common shares sold at $300.50 per share. This price reflects the execution level for the open-market sale disclosed, providing investors with insight into the approximate valuation at the time of the trade.

Was the JLL director’s share sale made under a Rule 10b5-1 plan?

Yes. The footnote states the 2,500 shares were sold under a Rule 10b5-1(c) trading plan adopted on December 9, 2025. Such plans pre-schedule trades, reducing the significance of trade timing as a signal of insider sentiment.

Does this JLL Form 4 involve any derivative securities or option exercises?

No derivative securities or option exercises are reported in this Form 4. The filing shows only a non-derivative transaction: an open-market sale of 2,500 common shares, with derivativeSummary indicating no derivative positions referenced in this specific disclosure.